Results: 1-25 | 26-50 | 51-54
Results: 1-25/54

Authors: Kanzawa, F Koizumi, F Koh, Y Nakamura, T Tatsumi, Y Fukumoto, H Saijo, N Yoshioka, T Nishio, K
Citation: F. Kanzawa et al., In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction, CLIN CANC R, 7(1), 2001, pp. 202-209

Authors: Sekine, I Saijo, N
Citation: I. Sekine et N. Saijo, Polymorphisms of metabolizing enzymes and transporter proteins involved inthe clearance of anticancer agents, ANN ONCOL, 12(11), 2001, pp. 1515-1525

Authors: Tatsumi, Y Arioka, H Ikeda, S Fukumoto, H Miyamoto, K Fukuoka, K Ohe, Y Saijo, N Nishio, K
Citation: Y. Tatsumi et al., Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6, JPN J CANC, 92(7), 2001, pp. 768-777

Authors: Nakamura, T Koizumi, F Kaneko, N Tamura, T Chiwaki, F Koh, Y Akutagawa, S Saijo, N Nishio, K
Citation: T. Nakamura et al., Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519, JPN J CANC, 92(6), 2001, pp. 597-602

Authors: Shimizu, M Tamura, T Yamada, Y Akiyama, Y Saijo, N Nishio, K
Citation: M. Shimizu et al., CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNAin mouse liver, JPN J CANC, 92(5), 2001, pp. 554-561

Authors: Inoue, A Saijo, N
Citation: A. Inoue et N. Saijo, Recent advances in the chemotherapy of non-small cell lung cancer, JPN J CLIN, 31(7), 2001, pp. 299-304

Authors: Kurata, T Tamura, T Shinkai, T Ohe, Y Kunitoh, H Kodama, T Kakinuma, R Matsumoto, T Kubota, K Omatsu, H Nishiwaki, Y Saijo, N
Citation: T. Kurata et al., Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer, JPN J CLIN, 31(3), 2001, pp. 93-99

Authors: Ohe, Y Niho, S Kakinuma, R Kubota, K Matsumoto, T Ohmatsu, H Goto, K Kunitoh, H Saijo, N Nishiwaki, Y
Citation: Y. Ohe et al., Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients, JPN J CLIN, 31(3), 2001, pp. 100-106

Authors: Akiyama, Y Ohe, Y Tamura, T Sawada, M Inoue, A Kusaba, H Yamamoto, N Sekine, I Kunitoh, H Kodama, T Saijo, N
Citation: Y. Akiyama et al., A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer, JPN J CLIN, 31(10), 2001, pp. 482-487

Authors: Tsuchiya, S Ohe, Y Sugiura, T Fuwa, N Kitamoto, Y Mori, K Kobayashi, H Nakata, K Sawa, T Hirai, K Etoh, T Saka, H Saito, A Fukuda, H Ishizuka, N Saijo, N
Citation: S. Tsuchiya et al., Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601), JPN J CLIN, 31(10), 2001, pp. 488-494

Authors: Inoue, A Kunitoh, H Sekine, I Sumi, M Tokuuye, K Saijo, N
Citation: A. Inoue et al., Radiation pneumonitis in lung cancer patients: A retrospective study of risk factors and the long-term prognosis, INT J RAD O, 49(3), 2001, pp. 649-655

Authors: Saijo, N Tamura, T Yamamoto, N Nishio, K
Citation: N. Saijo et al., New strategies for cancer therapy in the 21st century, CANC CHEMOT, 48, 2001, pp. S102-S106

Authors: Tsunoda, T Nakamura, T Ishimoto, K Yamaue, H Tanimura, H Saijo, N Nishio, K
Citation: T. Tsunoda et al., Upregulated expression of angiogenesis genes and down regulation of cell cycle genes in human colorectal cancer tissue determined by cDNA macroarray, ANTICANC R, 21(1A), 2001, pp. 137-143

Authors: Kunitoh, H Akiyama, Y Kusaba, H Yamamoto, N Sekine, I Ohe, Y Kubota, K Tamura, T Shinkai, T Kodama, T Goto, K Niho, S Nishiwaki, Y Saijo, N
Citation: H. Kunitoh et al., A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer, LUNG CANC, 33(2-3), 2001, pp. 259-265

Authors: Natsume, T Nakamura, T Koh, Y Kobayashi, M Saijo, N Nishio, K
Citation: T. Natsume et al., Gene expression profiling of exposure to TZT-1027, a novel microtubule-interfering agent, in non-small cell lung cancer PC-14 cells and astrocytes, INV NEW DR, 19(4), 2001, pp. 293-302

Authors: Fukuoka, K Usuda, J Iwamoto, Y Fukumoto, H Nakamura, T Yoneda, T Narita, N Saijo, N Nishio, K
Citation: K. Fukuoka et al., Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells, INV NEW DR, 19(3), 2001, pp. 219-227

Authors: Greco, FA Saijo, N
Citation: Fa. Greco et N. Saijo, Current perspectives in the treatment of small cell lung cancer - Introduction, SEMIN ONCOL, 28(2), 2001, pp. 1-2

Authors: Tsukada, H Yokoyama, A Goto, K Takada, M Saijo, N
Citation: H. Tsukada et al., Concurrent versus sequential radiotherapy for small cell lung cancer, SEMIN ONCOL, 28(2), 2001, pp. 23-26

Authors: Yoshida, M Feng, WJ Nishio, K Takahashi, M Heike, Y Saijo, N Wakasugi, H Ikekawa, T
Citation: M. Yoshida et al., Antitumor action of the PKC activator gnidimacrin through cdk2 inhibition, INT J CANC, 94(3), 2001, pp. 348-352

Authors: Usuda, J Okunaka, T Furukawa, K Tsuchida, T Kuroiwa, Y Ohe, Y Saijo, N Nishio, K Konaka, C Kato, H
Citation: J. Usuda et al., Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis, INT J CANC, 93(4), 2001, pp. 475-480

Authors: Heike, Y Kasono, K Kunisaki, C Hama, S Saijo, N Tsuruo, T Kuntz, DA Rose, DR Curiel, DT
Citation: Y. Heike et al., Overcoming multi-drug resistance using an intracellular anti-MDR1 sFv, INT J CANC, 92(1), 2001, pp. 115-122

Authors: Nishio, K Nakamura, T Koh, Y Kanzawa, F Tamura, T Saijo, N
Citation: K. Nishio et al., Oncoprotein 18 overexpression Increases the sensitivity to vindesine in the Human hung Carcinoma Cells, CANCER, 91(8), 2001, pp. 1494-1499

Authors: Kubota, K Tamura, T Fukuoka, M Furuse, K Ikegami, H Ariyoshi, Y Kurita, Y Saijo, N
Citation: K. Kubota et al., Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902, ANN ONCOL, 11(4), 2000, pp. 445-450

Authors: Kuh, HJ Nakagawa, S Usuda, J Yamaoka, K Saijo, N Nishio, K
Citation: Hj. Kuh et al., A computational model for quantitative analysis of cell cycle arrest and its contribution to overall growth inhibition by anticancer agents, JPN J CANC, 91(12), 2000, pp. 1303-1313

Authors: Yamamoto, N Tamura, T Kamiya, Y Sekine, I Kunitoh, H Saijo, N
Citation: N. Yamamoto et al., Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol, J CL ONCOL, 18(11), 2000, pp. 2301-2308
Risultati: 1-25 | 26-50 | 51-54